Zhijie Kang
Liaoning Key Laboratory Of Hematopoietic Stem Cell Transplantation And Translational Medicine
Dalian, China
Dalian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
MBP1 inhibits AML proliferation through downregulating noncanonical Wnt/Ca2+ signaling pathway.
Journal: Leukemia & lymphoma
Published: April 23, 2026
The impact of pretransplant consolidation chemotherapy on clinical outcomes in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: a single-center retrospective study.
Journal: Frontiers in oncology
Published: January 25, 2026
Bortezomib synergizes with homoharringtonine in FLT3-ITD-relapsed/refractory acute myeloid leukemia by inducing FLT3-ITD protein degradation.
Journal: Clinical and experimental medicine
Published: January 11, 2026
Social support and care burden in family caregivers of patients with hematologic malignancies: a parallel mediation model of coping strategies.
Journal: PeerJ
Published: December 22, 2025
Glymphatic system dysfunction and cognitive impairment in post-chemotherapy AML: A novel DTI-ALPS index study.
Journal: Brain research bulletin
Published: November 13, 2025
Efficacy and safety of ruxolitinib combined with steroids for first-line treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: a single-center, real-world experience.
Journal: Frontiers in immunology
Published: May 01, 2025
Next-Generation Sequencing for Characterizing Respiratory Tract Virome and Improving Detection of Viral Pathogens in Children With Pneumonia.
Journal: Influenza and other respiratory viruses
Published: May 15, 2024
EP300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia.
EP300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia.
Journal: Cell communication and signaling : CCS
Published: December 12, 2023
XPO1 is a new target of homoharringtonine (HHT): Making NPMc+ AML cells much more sensitive to HHT treatment.
Journal: Biochemical and biophysical research communications
Published: June 25, 2023
Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene.
Journal: Experimental hematology & oncology
Published: December 16, 2022
One novel ACOT7-NPHP4 fusion gene identified in one patient with acute lymphoblastic leukemia: a case report.
Journal: BMC medical genomics
Published: September 18, 2021
Targeting cancer cell plasticity by HDAC inhibition to reverse EBV-induced dedifferentiation in nasopharyngeal carcinoma.
Journal: Signal transduction and targeted therapy
Published: February 08, 2021
Last Updated: 09/26/2026